Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

173
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
173
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

368
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
368
Pericarditis I: Introduction01:22

Pericarditis I: Introduction

324
Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
324
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

1.8K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.8K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

722
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
722

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of a 22G Crown-Cut Needle with a Conventional 22G Needle with EBUS Guidance in Diagnosis of Sarcoidosis.

Lung·2022
Same author

[Linguistic Validation of the "German Lung Fibrosis Health Related Quality of Life Questionnaire"].

Pneumologie (Stuttgart, Germany)·2021
Same author

[German Guideline for Idiopathic Pulmonary Fibrosis].

Pneumologie (Stuttgart, Germany)·2020
Same author

Pneumologie (Stuttgart, Germany)·2020
Same author

[German Guideline for Idiopathic Pulmonary Fibrosis].

Pneumologie (Stuttgart, Germany)·2020
Same author

[The Role of Air Pollutants for Health - A Reply to the Expert Opinion of the International Society for Environmental Epidemiology (ISEE) and the European Respiratory Society (ERS)].

Pneumologie (Stuttgart, Germany)·2019
Same journal

Current status of lung transplantation.

The European respiratory journal. Supplement·2003
Same journal

Treatment of chronic respiratory failure: lung volume reduction surgery versus rehabilitation.

The European respiratory journal. Supplement·2003
Same journal

Home ventilation.

The European respiratory journal. Supplement·2003
Same journal

Mechanical ventilation: invasive versus noninvasive.

The European respiratory journal. Supplement·2003
Same journal

Respiratory failure in chronic obstructive pulmonary disease.

The European respiratory journal. Supplement·2003
Same journal

Physical and biological triggers of ventilator-induced lung injury and its prevention.

The European respiratory journal. Supplement·2003
See all related articles

Related Experiment Videos

Sarcoidosis: clinical update.

U Costabel1

  • 1Ruhr-landklinik, Dept Pneumology/Allergology, Essen, Germany.

The European Respiratory Journal. Supplement
|January 31, 2002
PubMed
Summary
This summary is machine-generated.

Sarcoidosis is a multisystem immune disorder. Diagnosis requires clinical, radiological, and histological evidence, with corticosteroids as primary therapy, but alternatives exist and treatment is reserved for symptomatic or organ-threatening cases.

Related Experiment Videos

Area of Science:

  • Immunology
  • Pulmonology
  • Rheumatology

Background:

  • Sarcoidosis is a multisystem inflammatory disease characterized by noncaseating granulomas.
  • Recent advances have refined the understanding of sarcoidosis pathogenesis and epidemiology.
  • International consensus statements provide updated guidance on diagnosis and management.

Purpose of the Study:

  • To summarize recent advances in sarcoidosis diagnosis and therapy.
  • To highlight current diagnostic criteria and treatment recommendations.
  • To emphasize a cautious approach to treatment, particularly for asymptomatic cases.

Main Methods:

  • Review of recent literature and international consensus statements on sarcoidosis.
  • Analysis of diagnostic criteria including clinical, radiological, and histological findings.
  • Evaluation of current therapeutic strategies, including corticosteroids and alternatives.

Main Results:

  • Sarcoidosis is defined as a multisystem disorder with a heightened cellular immune response.
  • Diagnosis relies on compatible clinical/radiological findings, noncaseating granulomas, and exclusion of other diseases.
  • Corticosteroids remain first-line therapy, with alternatives emerging; treatment is judiciously applied.

Conclusions:

  • Current understanding defines sarcoidosis as an immune-mediated disorder with environmental triggers.
  • Diagnosis requires a comprehensive approach excluding mimic diseases.
  • Treatment decisions should balance potential benefits against risks, favoring watchful waiting for asymptomatic pulmonary sarcoidosis.